Harvard Bioscience
HBIO
#8825
Rank
S$0.12 B
Marketcap
$2.91
Share price
0.00%
Change (1 day)
-48.52%
Change (1 year)

Harvard Bioscience (HBIO) - Cash on Hand

Cash on Hand as of June 2024 : S$5.44 Million

According to Harvard Bioscience's latest financial reports the company has S$5.44 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Harvard Bioscience - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$5.65 M-6.4%
2022-12-31S$6.04 M-42.84%
2021-12-31S$10.57 M-3.9%
2020-12-31S$11 M-2.08%
2019-12-31S$11.23 M0.64%
2018-12-31S$11.16 M60.79%
2017-12-31S$6.94 M-14.26%
2016-12-31S$8.09 M-15.1%
2015-12-31S$9.53 M-48.92%
2014-12-31S$18.67 M-42.8%
2013-12-31S$32.65 M29.1%
2012-12-31S$25.29 M9%
2011-12-31S$23.2 M-8.59%
2010-12-31S$25.38 M8.99%
2009-12-31S$23.28 M18.88%
2008-12-31S$19.58 M-23.9%
2007-12-31S$25.74 M79.41%
2006-12-31S$14.34 M12.91%
2005-12-31S$12.7 M-43.83%
2004-12-31S$22.62 M61.93%
2003-12-31S$13.97 M-47.42%
2002-12-31S$26.57 M-51.16%
2001-12-31S$54.39 M-12.37%
2000-12-31S$62.07 M1456.02%
1999-12-31S$3.98 M152.49%
1998-12-31S$1.58 M